Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs6872364 | chr5:7319767 | C/T | 9.46E-9 | 490 | 30.9 | 31.12 | 10.07 | KM Plot |
PRAD | rs6873948 | chr5:7322656 | T/C | 8.53E-10 | 488 | 31.07 | 31.12 | 10.07 | KM Plot |
PRAD | rs6874459 | chr5:77252012 | C/T | 2.65E-5 | 490 | 32.43 | 30.93 | 30.97 | KM Plot |
PRAD | rs6887339 | chr5:7326039 | A/G | 1.02E-8 | 488 | 30.8 | 31.93 | 10.07 | KM Plot |
PRAD | rs6887523 | chr5:7322389 | A/C | 0 | 494 | 4.87 | 31.3 | 30.9 | KM Plot |
PRAD | rs6895588 | chr5:154356186 | C/T | 0 | 485 | 30.27 | 33.07 | 5.58 | KM Plot |
PRAD | rs6895702 | chr5:154356068 | G/T | 0 | 488 | 30.33 | 32.52 | 4.87 | KM Plot |
PRAD | rs6895741 | chr5:154203264 | G/A | 8.86E-9 | 491 | 30.3 | 33.27 | 20.47 | KM Plot |
PRAD | rs6903728 | chr6:18837098 | A/G | 2.11E-5 | 483 | 30.93 | 31.13 | 25.27 | KM Plot |
PRAD | rs6934291 | chr6:19164056 | G/A | 0.000175 | 491 | 28.57 | 32.23 | 30.2 | KM Plot |
PRAD | rs6941129 | chr6:42955101 | C/T | 7.7E-5 | 493 | 30.53 | 32.18 | 24.13 | KM Plot |
PRAD | rs6961685 | chr7:135115985 | T/C | 1.95E-9 | 493 | 30.77 | 31.9 | 3.03 | KM Plot |
PRAD | rs6989962 | chr8:143452518 | G/A | 1.23E-5 | 489 | 30.8 | 31.43 | 28.77 | KM Plot |
PRAD | rs6999707 | chr8:140963102 | C/T | 4.01E-5 | 494 | 28.3 | 29.57 | 31.87 | KM Plot |
PRAD | rs7014127 | chr8:71541063 | T/C | 4.69E-5 | 492 | 30.93 | 31.57 | 24.27 | KM Plot |